决定异体 CAR T 细胞排斥与扩增的细胞和分子机制
Cellular and molecular mechanisms determining allogeneic CAR T cell rejection and expansion.
我们评估了11例接受单一批次cemacabtagene ansegedleucel(cema-cel)治疗的大B细胞淋巴瘤患者,cemacabtagene ansegedleucel是一种异体抗CD19 CAR T产品。
英文原题:Single-cell sequencing reveals dynamic immune features of paraneoplastic pemphigus in a patient with follicular lymphoma.
我们的研究描绘了一名FL相关PNP患者在整个治疗过程中的动态免疫景观。这是一项描述性、产生假设的单患者研究;研究结果具有探索性,不可推广,且不能确立因果关系。所观察到的变化与治疗后免疫重塑相符,涉及特异性T细胞反应和TCR克隆扩增。这项纵向单细胞分析描述了一名FL相关PNP患者中观察到的免疫景观,并揭示了与治疗反应相关的动态特征,为未来研究提供了资源和假设。
副肿瘤性天疱疮(PNP)是一种高度致命的自身免疫性大疱性疾病,常发生于患有潜在良性或恶性肿瘤的患者。它给诊断和治疗带来了重大挑战。迄今为止,PNP发病机制背后的细胞和分子机制在很大程度上仍不清楚。
本研究旨在通过分析治疗全过程中的动态免疫格局,阐明PNP的细胞和分子机制,尤其是当它继发于淋巴瘤时。
我们对一名伴有PNP的滤泡性淋巴瘤(FL)患者的外周血单个核细胞(PBMCs)和骨髓细胞(BMCs)进行了单细胞转录组测序和单细胞T细胞受体(TCR)分析。样本采集于三个关键时间点:治疗前、治疗期间和治疗成功后。
以公共数据集作为定性参考,我们探索性地将患者细胞频率与已发表健康对照进行了比较。在这些探索性对比中,我们观察到PBMCs中ITGAL + T细胞、TRDV1偏向性T细胞簇和BCL2 + B细胞明显相对丰富。在BMCs中,我们注意到包括na ve T细胞和某些B细胞簇在内的明显差异。单细胞转录组结果描述了淋巴瘤相关肿瘤微环境,并揭示了治疗后的免疫重塑。这种重建涉及激活的DNA损伤和T细胞免疫反应,随着治疗进展逐渐扩增的TCR克隆的观察进一步支持了这一点。
BACKGROUND: Paraneoplastic pemphigus (PNP) is a highly fatal autoimmune blistering disease that commonly occurs in patients with underlying benign or malignant neoplasms. It poses significant challenges for diagnosis and treatment. To date, the cellular and molecular mechanisms underlying the pathogenesis of PNP remain largely unclear. OBJECTIVE: This study aims to elucidate the cellular and molecular mechanisms of PNP, particularly when it occurs secondary to lymphoma, by analyzing the dynamic immune landscape throughout the course of treatment. METHOD: We performed single-cell transcriptome sequencing and single-cell T cell receptor (TCR) analysis on peripheral blood mononuclear cells (PBMCs) and bone marrow cells (BMCs) obtained from a patient with follicular lymphoma (FL) accompanied by PNP. Samples were collected at three critical time points: before treatment, during treatment, and after successful treatment. RESULT: Using public datasets as a qualitative reference, we exploratorily compared patient cell frequencies to published healthy controls. In these exploratory contrasts, we observed an apparent relative abundance of ITGAL + T cells, TRDV1 -biased T-cell clusters, and BCL2 + B cells in PBMCs. In BMCs, we noted apparent differences including na ve T cell and certain B cell clusters. The single-cell transcriptome results described the lymphoma-associated tumor microenvironment and revealed post-treatment immune remodeling. This reconstitution involved activated DNA damage and T cell immune responses, which was further supported by the observation of a gradually expanded TCR clone as the treatment progressed. CONCLUSION: Our study delineates the dynamic immune landscape in a patient with FL-associated PNP throughout treatment. This is a descriptive, hypothesis-generating single-patient study; findings are exploratory, not generalizable, and do not establish causality. The observed changes are compatible with post-treatment immune remodeling involving specific T cell responses and TCR clone expansion. This longitudinal single-cell analysis describes the immune landscape observed in a patient with FL-associated PNP and reveals dynamic features associated with treatment response, providing a resource and generating hypotheses for future study.
MEMBER ACCOUNT
登录成功会直接打开下一页。